Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation
- PMID: 39717778
- PMCID: PMC11663739
- DOI: 10.3389/fimmu.2024.1440314
Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation
Abstract
Introduction: To analyze the molecular pathogenesis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a small animal model such as mice is needed: human angiotensin converting enzyme 2 (hACE2), the receptor of SARS-CoV-2, needs to be expressed in the respiratory tract of mice.
Methods: We conferred SARS-CoV-2 susceptibility in mice by using an adenoviral vector expressing hACE2 driven by an elongation factor 1α (EF1α) promoter with a leftward orientation.
Results: In this model, severe pneumonia like human COVID-19 was observed in SARS-CoV-2-infected mice, which was confirmed by dramatic infiltration of inflammatory cells in the lung with efficient viral replication. An early circulating strain of SARS-CoV-2 caused the most severe weight loss when compared to SARS-CoV-2 variants such as Alpha, Beta and Gamma, although histopathological findings, viral replication, and cytokine expression characteristics were comparable.
Discussion: We found that a distinct proteome of an early circulating strain infected lung characterized by elevated complement activation and blood coagulation, which were mild in other variants, can contribute to disease severity. Unraveling the specificity of early circulating SARS-CoV-2 strains is important in elucidating the origin of the pandemic.
Keywords: COVID-19; SARS-CoV-2; adenoviral vector; mouse model; proteomics.
Copyright © 2024 Matsumoto, Honda, Yasui, Endo, Sanada, Toyama, Takagi, Munakata, Kono, Yamaji, Yamamoto, Saeki and Kohara.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20. J Virol. 2022. PMID: 34668780 Free PMC article.
-
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.Am J Respir Cell Mol Biol. 2021 Jan;64(1):79-88. doi: 10.1165/rcmb.2020-0354OC. Am J Respir Cell Mol Biol. 2021. PMID: 32991819 Free PMC article.
-
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.Emerg Microbes Infect. 2020 Dec;9(1):2433-2445. doi: 10.1080/22221751.2020.1838955. Emerg Microbes Infect. 2020. PMID: 33073694 Free PMC article.
-
Variants in ACE2; potential influences on virus infection and COVID-19 severity.Infect Genet Evol. 2021 Jun;90:104773. doi: 10.1016/j.meegid.2021.104773. Epub 2021 Feb 17. Infect Genet Evol. 2021. PMID: 33607284 Free PMC article. Review.
-
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10. Biomed Pharmacother. 2022. PMID: 34906769 Free PMC article. Review.
References
-
- Chan JF, Zhang AJ, Yuan S, Poon VK, Chan CC, Lee AC, et al. . Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden syrian hamster model: Implications for disease pathogenesis and transmissibility. Clin Infect Dis. (2020) 71(9):2428–46. doi: 10.1093/cid/ciaa325 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous